Advanced search
346
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Is CD30 a predictive biomarker for brentuximab vedotin?

Pages 1524-1525
Received 25 Dec 2016
Accepted 26 Dec 2016
Published online: 06 Feb 2017

Potential conflict of interest

Disclosure forms provided by the author is available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2017.1283687.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
EUR 51.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
EUR 789.00 Add to cart

Purchase access via tokens

  • Choose from packages of 10, 20, and 30 tokens
  • Can use on articles across multiple libraries & subject collections
  • Article PDFs can be downloaded & printed
From EUR 400.00
per package
Learn more
* Local tax will be added as applicable
 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.